Bushehr Research Center for Nuclear Medicine and Molecular Imaging (NMMI.IR)
219 subscribers
486 photos
15 videos
37 files
72 links
Mini Medical School for the Public
Admin: @Bushnmmi
Download Telegram
to view and join the conversation
A breakthrough project on 177Lu-FAPI came out.
Bushehr Research Center for Nuclear Medicine and Molecular Imaging (NMMI.IR)
همکاری مرکز تحقیقات پزشکی هسته ای دانشگاه علوم پزشکی بوشهر در برجسته ترین رویداد پزشکی هسته ای هندوستان
In the CONCORD-3 study, 5 years of survival of cancer patients registered during 15 years using 322 population-based cancer registries in 71 countries. The study includes 18 types of cancer.
It demonstrated different results up to types of cancer.
Population-based cancer registries as key policy tools to assess either the impact of cancer prevention strategies or the effectiveness of health systems for all patients diagnosed with cancer.

A cancer registry transcribes the nuts and bolts of the management into different geographical scale databases to assist researchers and practitioners track cancer trends.

It holds true in Theranostics:
Think holistically , act molecularly!?
Targeted Alpha Therapeutic Studies classified in Different Clinical Trial Phases
Obesity, cancer and theranostics efficacy: challenges and opportunities

The rates of cancer seem to be inversely proportional to animal body size (Peto’s paradox; elephants <<<<< mice) mostly due to metabolic issues e.g. elephants have 20 copies of the TP53 gene while human very few.

The causal effect of body size and composition and risk of site-specific cancers in human studies is mixed.

Association between BMI and cancer survival in human studies: not consistent across cancer types and stages.

High BMI seems to be independently associated with improved survival in immunotherapy of patients with NSCLC.

It seems that there is decreased efficacy of cancer treatment among obese patients for some types of treatments, especially chemotherapy.
Little evidence indicating that weight loss for cancer patients would confer improved survival but did not take into account potential improvements in treatment efficacy.

It seems that increased physical activity may improve disease-free survival, with a potentially stronger impact among obese ones.

What about such issues in THERANOSTICS?

Think holistically, act moleculary
Bushehr Research Center for Nuclear Medicine and Molecular Imaging (NMMI.IR)
Talk on “Targeted Alpha Therapy (TAT)” in a multidisciplinary webinar five days ago aiming to provide an outline of latest advances on TAT in current oncological context.
The file is loaded in researchgate website: